Infection fatality risk for SARS-CoV-2: a nationwide seroepidemiological study in the non-institutionalized population of Spain
Roberto Pastor‐Barriuso(Instituto de Salud Carlos III), Marina Pollán(Instituto de Salud Carlos III), Inmaculada León-Gómez(Instituto de Salud Carlos III), Mayte Pérez‐Olmeda(Instituto de Salud Carlos III), Jose L Sanmartín(Ministry of Health), Juan F Muñoz-Montalvo(Ministry of Health), Beatriz Pérez‐Gómez(Instituto de Salud Carlos III), Concepción Delgado‐Sanz(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Raquel Yotti(Instituto de Salud Carlos III), José León Paniagua(Instituto de Salud Carlos III), Miguel A. Hernán(Harvard University), Pablo Fernández‐Navarro, Israel Cruz(Instituto de Salud Carlos III), Mariano Martín(Ministry of Health), Nerea Fernández‐de‐Larrea(Instituto de Salud Carlos III), Faustino Blanco(Ministry of Health), Aurora Fernández-García
Cited by 51
Related Papers
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
|BMJ|2017|1.8k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784